Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma of Lung × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 12 Breast Neoplasms 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 10 Neoplasms 8 Melanoma 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Lymphoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Carboplatin 22 Bevacizumab 17 Paclitaxel 16 Pemetrexed 14 Radiotherapy 11 Erlotinib Hydrochloride 11 Docetaxel 7 Gemcitabine 5 Cetuximab 5 ceritinib 4 Taxes 4 Cisplatin 4 pembrolizumab 3 Surgical Procedures, Operative 3 Radiosurgery 3 Metformin 3 Gefitinib 3 Cyclophosphamide 3 pegfilgrastim 2 capmatinib 2 Thalidomide 2 Sorafenib 2 Radiotherapy, Conformal 2 Nivolumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Albumin-Bound Paclitaxel 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡